HYAL1 and neoplasm: HA, together with its receptor (CD44) and degradation enzymes (HYAL-1, etc.), acts as a carcinolytic agent, suppressing tumour growth and metastasis and this is evidenced by accumulation of HA and its associated degradation enzymes within malignant tumours [29].